CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Mirae Launches With $5.4M in Funding to Expand Access to World-Class Specialty Care

Positive
AI Analysis

Summary

Mirae launches with $5.4M in funding to expand access to specialty care using AI technology for patients with autoimmune disease and complex chronic conditions. The AI companion platform helps patients track symptoms, understand their condition, and detect flares earlier.

Importance:3/10
Sentiment:
0.60
fundingAIautoimmune diseasechronic conditionspatient monitoring
Related Companies

Read the original article

Published by PR Newswire Biotech on July 28, 2026 4:00 PM

Read Original